Wall Street Futures Rise Ahead of Trump-Xi Summit as Tech Stocks Lead Market Rally 
Oil Prices Slip as Strait of Hormuz Disruptions and U.S. Inventory Data Keep Markets on Edge 
Japan Considers Extra Budget Aid Amid Rising Fuel and Utility Costs 
Dollar Gains as Fed Rate Hike Bets Rise Ahead of Trump-Xi Summit 
Asian Stocks Steady as Iran War Concerns Persist Ahead of Trump-Xi Summit 
Asian Currencies Slide as Indian Rupee Hits Record Low Amid Iran Tensions 
U.S. Urges China to Help Curb Iran’s Actions in Gulf, Rubio Says 
S&P Global Revises Mexico Credit Outlook to Negative Amid Rising Debt Concerns 
Havana Protests Erupt as Cuba Faces Severe Blackouts and Fuel Crisis 
Dollar Surges as Inflation Data Fuels Fed Rate Hike Expectations 
Trump, Xi Begin High-Stakes China Summit Focused on Trade, Taiwan and Global Tensions 
New Zealand Budget 2026 Focuses on Fiscal Discipline and Infrastructure Investment 
US Stock Futures Slip as Iran Tensions and Hot Inflation Data Pressure Wall Street 
ASX Names Former Euronext Executive Anthony Attia as New CEO 
Asian Stocks Edge Higher as Tech Shares Rise Ahead of Trump-Xi Beijing Summit 
Oil Prices Hold Above $100 as Trump-Xi Meeting and Iran Conflict Keep Markets on Edge 
BOJ Rate Hike Expectations Grow as Board Member Signals Hawkish Stance 
Eli Lilly to Introduce Mounjaro Weight-Loss Drug in Hong Kong by Year-End
Global pharmaceutical giant Eli Lilly is gearing up to launch its weight-loss drug, Mounjaro, in Hong Kong by the end of this year. According to a report from Bloomberg News, the company has received approval from Hong Kong's government to sell its tirzepatide injections under the Mounjaro brand.
Mounjaro for Weight Management and Diabetes
Eli Lilly's Mounjaro is designed for both long-term weight management and the treatment of type 2 diabetes. It will be available on the Kwikpen device, which allows for easy self-administration. The company aims to address the growing demand for effective weight-loss treatments while continuing to provide solutions for diabetes management.
Hong Kong Market Entry
Hong Kong marks a strategic entry point for Eli Lilly as it expands its global presence. With the approval of Mounjaro, the company is poised to offer a highly anticipated solution for individuals struggling with obesity and related health issues. The weight-loss sector has seen significant growth in recent years, and Mounjaro is expected to make a notable impact.
